A trusted source told me that Dr. Menon said the purpose of the interim analysis is to use the data to look for a partner. Remember, CTIX proposed the analysis, not the FDA. Leo knows that the FDA won't approve B after just 200 patients. It's funny that bashers always call Leo a liar, but they believe him on no partnership until P3 is completed.

Quote:

---

Correcting a basher lie elsewhere: it was stated that Leo said there would be no partnership deals until Phase 3 was COMPLETED. This is not true. Leo said that he would not make a deal until Phase 3, period. In other words, he can make a deal at any time when Phase 3 commences.

---